FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL MANAGEMENT, L.L.C.

Institutional investor · Portfolio as of Q4 2023

SEC EDGAR SourceSEC Filings

Top Holdings158 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
SPYSPY
PUT

STATE STREET SPDR S&P 500 ETF TRUST CL USD INC

12.3M$5.9B26.8%
Increased

PIONEER NATURAL RESOURCE

3.1M$701.6M3.2%
1 qtr
New
88

IQVIA HOLDINGS INC

3M$685.1M3.1%$164.12+40.98%
21 qtrssince 2018-Q4
Increased
62

EXELIXIS INC

26.6M$639M2.9%$19.09+25.67%
21 qtrssince 2018-Q4
Increased
56

THERMO FISHER SCIENTIFIC INC

1.2M$638.6M2.9%$432.36+22.00%
17 qtrssince 2019-Q4
Increased
62

UNITEDHEALTH GROUP INC

1.2M$633.1M2.9%$451.25+12.11%
4 qtrssince 2023-Q1
Decreased
0

TRANSUNION

9.1M$626.8M2.9%$86.03-20.94%
21 qtrssince 2018-Q4
Decreased
0

SALESFORCE.COM INC

1.9M$506.7M2.3%$173.51+49.84%
17 qtrssince 2019-Q4
Decreased
0

MICROSOFT CORP

1.3M$503.4M2.3%$214.60+72.66%
21 qtrssince 2018-Q4
Decreased
0

WABTEC CORP

3.9M$499.8M2.3%$82.10+53.04%
21 qtrssince 2018-Q4
Increased
64

ARAMARK

16.9M$474.9M2.2%$25.48+7.26%
13 qtrssince 2020-Q4
Increased
71

NEW YORK TIMES CO-A

9.5M$464.3M2.1%$41.18+16.00%
15 qtrssince 2020-Q2
Increased
63

ALPHABET INC-CL C

3.1M$442.3M2.0%$98.46+42.06%
21 qtrssince 2018-Q4
Decreased
0

HESS CORP

3M$428.9M2.0%
1 qtr
New
71

CBRE GROUP INC - A

4.2M$395.3M1.8%$73.86+26.04%
2 qtrssince 2023-Q3
Decreased
0

S&P GLOBAL INC

882,595$388.8M1.8%$318.41+36.27%
7 qtrssince 2022-Q2
Decreased
0

NASDAQ OMX GROUP/THE

6.6M$382M1.7%$56.48+0.26%
2 qtrssince 2023-Q3
Increased
79

BOSTON SCIENTIFIC CORP

5.8M$336.5M1.5%$41.25+40.16%
14 qtrssince 2020-Q3
Increased
56

INTUIT INC

533,000$333.1M1.5%$381.37+61.55%
5 qtrssince 2022-Q4
Decreased
0

CHARTER COMMUNICATIONS INC - CLASS A

799,141$310.6M1.4%$439.82-67.24%
2 qtrssince 2023-Q3
Decreased
0
$21.9B
AUM
158
Positions
Q4 2023
Filing
Rating · 1.5
Quarterly Portfolio Change
-1%Q3'22$18.2B-7%Q4'22$16.9B+8%Q1'23$18.3B+9%Q2'23$19.9B+8%Q3'23$21.4B+2%Q4'23$21.9B
Activity profile
$ moved · Q4'23
New12%Increased37%Decreased11%Exited39%
Composition
Equity vs derivatives
Equity73%Puts27%Calls0%
Holding period
Avg 2.1 years
<1Q14%1-4Q19%1-2Y20%2Y+47%

FARALLON CAPITAL MANAGEMENT, L.L.C. manages $21.9B across 158 positions as of Q4 2023. Top holdings: SPY (26.8%), PXD (3.2%), IQV (3.1%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 1.5/5.0.

Q4 2023 Summary

Active quarter - 28 new positions, 34 exits, 31 increased. Top move: PXD (NEW, conviction 88). Portfolio: $21.9B across 158 positions.

Top holdings by portfolio weight

Total AUM$16B
PXD3.21%
IQV3.13%
EXEL2.92%
TMO2.92%
UNH2.90%
TRU2.87%
CRM2.32%
MSFT2.30%
WAB2.29%
ARMK2.17%
Other2.12%

Portfolio allocation by GICS sector

Sectors11
Healthcare35.70%
Technology14.35%
Financial Services13.50%
Unknown12.68%
Industrials8.68%
Communication Services7.85%
Real Estate4.81%
Basic Materials1.74%
Consumer Cyclical0.31%
Utilities0.26%
Other0.12%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Technology, Financial Services
Compare DNA across all funds
7-dimension quality assessment
Below Average(1.5 / 5.0)
Track Record60
Conviction43
Concentration66
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
CRNXCRNXCRINETICS PHARMACEUTICALS IN
Q3 2024 Q2 2026+8.5M shares+$314.1M
7Q
BBIOBBIOBRIDGEBIO PHARMA INC
Q4 2024 Q2 2026+9M shares+$755.7M
5Q
BSXBSXBOSTON SCIENTIFIC CORP
Q2 2025 Q2 2026+6.8M shares+$69.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used